Discover how the PARK2 gene reduces migration and invasion while deregulating metabolic pathways in clear cell renal cell carcinoma (ccRCC).
Exploring how VHL protein dysfunction drives kidney cancer and the innovative therapies targeting this pathway.
Discover how calycosin, a plant-derived flavonoid, inhibits renal cell carcinoma by targeting the MAZ/HAS2 signaling pathway.